These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26382601)

  • 1. Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice.
    Živković I; Bufan B; Petrušić V; Minić R; Arsenović-Ranin N; Petrović R; Leposavić G
    Vaccine; 2015 Oct; 33(42):5546-5552. PubMed ID: 26382601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type.
    Živković I; Petrović R; Arsenović-Ranin N; Petrušić V; Minić R; Bufan B; Popović O; Leposavić G
    Biologicals; 2018 Mar; 52():18-24. PubMed ID: 29426673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain specificities in influence of ageing on germinal centre reaction to inactivated influenza virus antigens in mice: Sex-based differences.
    Bufan B; Arsenović-Ranin N; Petrović R; Živković I; Stoiljković V; Leposavić G
    Exp Gerontol; 2020 May; 133():110857. PubMed ID: 32006634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse strain and sex as determinants of immune response to trivalent influenza vaccine.
    Petrović R; Bufan B; Arsenović-Ranin N; Živković I; Minić R; Radojević K; Leposavić G
    Life Sci; 2018 Aug; 207():117-126. PubMed ID: 29859986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
    Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single immunization with MF59-adjuvanted inactivated whole-virion H7N9 influenza vaccine provides early protection against H7N9 virus challenge in mice.
    Chang H; Duan J; Zhou P; Su L; Zheng D; Zhang F; Fang F; Li X; Chen Z
    Microbes Infect; 2017 Dec; 19(12):616-625. PubMed ID: 28899814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
    Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
    Front Immunol; 2018; 9():2312. PubMed ID: 30356772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
    Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
    Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
    Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of aging on germinal centre reaction and antibody response to inactivated influenza virus antigens in mice: sex-based differences.
    Arsenović-Ranin N; Petrović R; Živković I; Bufan B; Stoiljković V; Leposavić G
    Biogerontology; 2019 Aug; 20(4):475-496. PubMed ID: 31049769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG subclass antibody responses in children vaccinated with influenza virus antigens by live attenuated or inactivated vaccines.
    Garcon NM; Groothuis J; Brown S; Lauer B; Pietrobon P; Six HR
    Antiviral Res; 1990 Aug; 14(2):109-16. PubMed ID: 2275526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice.
    Voutssas-Lara J; Cervantes-Torres J; Hernández M; Bobes RJ; Lamoyi E; Vázquez-Ramírez RA; Mendoza L; Reyes-Barrera KL; López-Martínez R; Alpuche-Solís ÁG; Rosales-Mendoza S; Huerta L; Fragoso G; Sciutto E
    Mol Immunol; 2021 Jul; 135():398-407. PubMed ID: 34022515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
    Wang S; Parker C; Taaffe J; Solórzano A; García-Sastre A; Lu S
    Vaccine; 2008 Jul; 26(29-30):3626-33. PubMed ID: 18538900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.